Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Member News
November 13, 2025Oswego Health Strengthens Therapy Services with Addition of King and MyersOswego Health is excited to announce that Michele R. King, MS, OTR/L, and Jason A. Myers, PT, former owners of Fyzical Therapy & Balance Centers, Inc., have officially joined the Oswego Health Therapy Services team. |
November 10, 2025Three Nave Law Attorneys Named Super Lawyers Rising Stars for 2025Nave Law Firm is proud to announce that three of its attorneys have been recognized by Super Lawyers as Rising Stars for 2025 — a distinction awarded to only 2.5% of attorneys in each state who demonstrate exceptional skill,… |
